AHR and prostate carcinoma: One such cross-talk can represent AhR-mediated AR degradation, since AhR has been demonstrated as a ligand-dependent E3 ubiquitin ligase that induces proteasomal degradation of AR in the androgen-sensitive prostate cancer cell line LNCaP [19].